{
    "clinical_study": {
        "@rank": "99036", 
        "arm_group": {
            "arm_group_label": "Ablation / MRI", 
            "arm_group_type": "Other", 
            "description": "All subjects will undergo a standard of care ablation procedure for paroxysmal AF with the CE-Marked PVAC GOLD catheter.\nMRIs will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at Pre-Discharge will undergo another MRI at the 1 month follow-up visit."
        }, 
        "brief_summary": {
            "textblock": "PRECISION GOLD is a prospective, multi-center, single arm, unblinded interventional post\n      market clinical study conducted in Europe.  The purpose of the study is to evaluate\n      asymptomatic cerebral embolic (ACE) lesions in subjects with symptomatic paroxysmal atrial\n      fibrillation undergoing ablation with the Pulmonary Vein Ablation Catheter (PVAC) GOLD."
        }, 
        "brief_title": "PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD)", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Atrial Fibrillation", 
        "condition_browse": {
            "mesh_term": "Atrial Fibrillation"
        }, 
        "detailed_description": {
            "textblock": "10-12 centers in Europe will enroll up to 56 subjects who meet the inclusion/exclusion\n      criteria and provide consent to participate in the study.  Subjects will undergo an ablation\n      for paroxysmal AF with the Medtronic PVAC GOLD (CE-Mark).  To assess for ACE lesions, pre-\n      and post-ablation procedure cerebral MRIs will be done along with a neurological exam (Mini\n      Mental State Exam).  Subjects will be followed for 1 month post-procedure when a repeat MRI\n      and neurological exam will be conducted if the subject had a positive MRI at pre-hospital\n      discharge."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Symptomatic AF (>/=2 recurrent AF episodes that self terminate or AF </=48 hours that\n             are cardioverted)\n\n          -  Documentation of >/=1 paroxysmal AF events within past year\n\n          -  AF symptoms (e.g. palpitations, fatigue, exertional dyspnea, effort intolerance)\n\n          -  Prescribed to vitamin K antagonist (e.g. warfarin/coumadin)\n\n          -  Age 18-70 years old\n\n          -  Clinically indicated for a pulmonary vein ablation\n\n          -  Willing and able to give informed consent\n\n          -  Willing, able and committed to participate in all study required activities for the\n             duration of the study\n\n        Exclusion Criteria:\n\n          -  Diagnosis of persistent or permanent AF\n\n          -  Prior left atrial ablation\n\n          -  Presence of intracardiac thrombus\n\n          -  Contraindicated for vitamin K antagonist\n\n          -  Prescribed to direct thrombin or factor inhibitors (e.g. dabigatran, rivaroxaban)\n\n          -  Prescribed to any investigational drug that may confound the study results\n\n          -  Cardiac valve prosthesis\n\n          -  Significant congenital heart defect (corrected or not)\n\n          -  Pulmonary vein stents\n\n          -  Pre-existing pulmonary vein stenosis\n\n          -  Cerebral ischemic event (e.g. stroke, TIA) that occurred within 6 months of study\n             consent date\n\n          -  If female - pregnancy\n\n          -  Participation in any other cardiovascular clinical study\n\n          -  Contraindicated for MRI\n\n          -  Active sepsis\n\n          -  Blood clotting abnormalities (genetic)\n\n          -  Presence of left atrial myxoma\n\n          -  Venous filtering device (e.g. Greenfield filter)\n\n          -  Invasive cardiac procedure in past 90 days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "56", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01767558", 
            "org_study_id": "PRECISION GOLD"
        }, 
        "intervention": {
            "arm_group_label": "Ablation / MRI", 
            "description": "All subjects will undergo a standard of care ablation procedure for paroxysmal AF with the CE-Marked PVAC GOLD catheter.\nMRIs will be performed on all subjects at Enrollment and Pre-Discharge (Post Ablation). Subjects with a positive MRI (cerebral lesion) at Pre-Discharge will undergo another MRI at the 1 month follow-up visit.", 
            "intervention_name": "Ablation / MRI", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 10, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Antwerpen", 
                        "country": "Belgium"
                    }, 
                    "name": "ZNA Middelheim"
                }, 
                "investigator": {
                    "last_name": "Yves De Greef, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France"
                    }, 
                    "name": "Hopital Cardiolgique du Haut-Leveque"
                }, 
                "investigator": {
                    "last_name": "Meleze Hocini, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Berka", 
                        "country": "Germany"
                    }, 
                    "name": "Zentraklinik Bad Berka"
                }, 
                "investigator": {
                    "last_name": "Christoph Geller, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bocholt", 
                        "country": "Germany"
                    }, 
                    "name": "St. Agnes Hospital Bocholt"
                }, 
                "investigator": {
                    "last_name": "Marcus Wieczorek, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany"
                    }, 
                    "name": "Zentrum fuer klinische Pruefungen in der Facharztzentrum Dresden-Neustadt GbR"
                }, 
                "investigator": {
                    "last_name": "Stefan Spitzer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debrecen", 
                        "country": "Hungary"
                    }, 
                    "name": "Debrecen University"
                }, 
                "investigator": {
                    "last_name": "Zoltan Csanadi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eindhoven", 
                        "country": "Netherlands"
                    }, 
                    "name": "Catharina Hospital"
                }, 
                "investigator": {
                    "last_name": "Lukas Dekker, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nieuwegein", 
                        "country": "Netherlands"
                    }, 
                    "name": "St. Antonius Hospital"
                }, 
                "investigator": {
                    "last_name": "Lucas Boersma, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eastbourne", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Eastbourne District General Hospital"
                }, 
                "investigator": {
                    "last_name": "Steve Furniss, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "University Hospital of South Manchester"
                }, 
                "investigator": {
                    "last_name": "Neil Davidson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle Upon Tyne", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Freeman Hospital"
                }, 
                "investigator": {
                    "last_name": "Stephen Murray, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France", 
                "Germany", 
                "Hungary", 
                "Netherlands", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Phased RF Evaluation of Acute Pulmonary Vein Isolation in Paroxysmal AF With New GENius UI and PVAC GOLD", 
        "overall_contact": {
            "email": "jason.d.foell@medtronic.com", 
            "last_name": "Jason Foell, PhD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "France: Institutional Ethical Committee", 
                "Germany: Ethics Commission", 
                "Hungary: Institutional Ethics Committee", 
                "Netherlands:  Independent Ethics Committee", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pre- and post-ablation MRIs will be evaluated for ACE lesions.  If the post-ablation MRI (within 16-72 hours) is positive for ACE, a repeat MRI will be completed at the 1 month visit.", 
            "measure": "Measure rate of post-procedure asymptomatic cerebral embolic (ACE) as determined by MRI", 
            "safety_issue": "No", 
            "time_frame": "1-45 days post-ablation procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01767558"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Acute procedural success is defined as:\nOnly PVAC GOLD catheters used to achieve pulmonary vein (PV) isolation\nAll accessible PVs were isolated (entrance block)\nSinus rhythm is restored at the end of the ablation procedure (with or without cardioversion)", 
                "measure": "Measure acute procedural success", 
                "safety_issue": "No", 
                "time_frame": "0-1 days after procedure"
            }, 
            {
                "measure": "Report procedure and/or device related serious adverse events using PVAC GOLD", 
                "safety_issue": "No", 
                "time_frame": "0-45 days post-ablation procedure"
            }
        ], 
        "source": "Medtronic Atrial Fibrillation Solutions", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Atrial Fibrillation Solutions", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}